What is the ticker symbol for Recursion Pharmaceuticals, Inc.?

The ticker symbol for Recursion Pharmaceuticals, Inc. is NASDAQ:RXRX

Does Recursion Pharmaceuticals, Inc. pay dividends?

No, Recursion Pharmaceuticals, Inc. does not pay dividends

What sector is Recursion Pharmaceuticals, Inc. in?

Recursion Pharmaceuticals, Inc. is in the Healthcare sector

What industry is Recursion Pharmaceuticals, Inc. in?

Recursion Pharmaceuticals, Inc. is in the Biotechnology industry

What country is Recursion Pharmaceuticals, Inc. based in?

Recursion Pharmaceuticals, Inc. is headquartered in United States

When did Recursion Pharmaceuticals, Inc. go public?

Recursion Pharmaceuticals, Inc. initial public offering (IPO) was on April 16, 2021

Is Recursion Pharmaceuticals, Inc. in the S&P 500?

No, Recursion Pharmaceuticals, Inc. is not included in the S&P 500 index

Is Recursion Pharmaceuticals, Inc. in the NASDAQ 100?

No, Recursion Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

Is Recursion Pharmaceuticals, Inc. in the Dow Jones?

No, Recursion Pharmaceuticals, Inc. is not included in the Dow Jones index

When was Recursion Pharmaceuticals, Inc. last earnings report?

Recursion Pharmaceuticals, Inc.'s most recent earnings report was on November 2, 2026

When does Recursion Pharmaceuticals, Inc. report earnings?

The next expected earnings date for Recursion Pharmaceuticals, Inc. is February 24, 2027

RXRX Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, RXRX price is $3.63, up +2.11% in the most recent trading session on November 11, 2026
Current Price All-Time High: RXRX price is currently -91.53% below its historical high of $42.81 set on July 13, 2021
Market Cap: RXRX current market cap is $2B, down -2.45% year-over-year
Revenue: RXRX current annual revenue is $74.68M, up +26.92% year-over-year
Next Earnings: The next earnings release for RXRX is on February 24, 2027

Profile

Company profile for Recursion Pharmaceuticals, Inc. (RXRX)
Metric	Value
Full Name	Recursion Pharmaceuticals, Inc.
Ticker	NASDAQ: RXRX
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology
Country	United States
IPO	Apr 16, 2021
Indexes	Not included
Website	recursion.com
Employees	800

Key Metrics

Recursion Pharmaceuticals, Inc. Key Details
Metric	Value	Date
Price	$3.63	Nov 11, 26
Price, 1D Change	+2.11%	Nov 11, 26
	$2B	Nov 11, 26
	-	Nov 11, 26
	-	Nov 11, 26
	2.80	Nov 10, 26
	$74.68M	Dec 31, 25
Revenue, 1Y Change	+26.92%	Dec 31, 25
	-$1.44	Dec 31, 25
EPS, 1Y Change	+14.78%	Dec 31, 25

Events

Recursion Pharmaceuticals, Inc. Events
Metric	Value	Date
Next Earnings		Feb 24, 27
Last Qtr. Earnings		Nov 2, 26
Last Ann. Earnings		Feb 25, 26
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	N/A	N/A
Next Split	N/A	N/A
Last Ticker Change	N/A	N/A
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

RXRX Estimates
Metric	Value	Date
	-$1.44	Dec 31, 25
EPS Estimate	-$0.88	Feb 24, 27
EPS Est. Change	+38.85%	Feb 24, 27
	$74.68M	Dec 31, 25
Revenue Estimate	$40.32M	Feb 24, 27
Revenue Est. Change	-46.01%	Feb 24, 27
Current Price	$3.63	Nov 11, 26
Price Target	$7.00	-
Price Tgt. Change	+93.10%	-

🔒 Log In To Unlock Full Data

EPS

RXRX EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	-$1.54	-$1.69	-9.71%
2025	-$1.60	-$1.44	+10.02%
2026	-$0.88	N/A	+38.85%
2027	-$0.83	N/A	+42.66%

Revenue

RXRX revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$67.80M	$58.84M	-13.22%
2025	$61.61M	$74.68M	+21.21%
2026	$40.32M	N/A	-46.01%
2027	$44.20M	N/A	-40.81%

🔒 Log In To Unlock Full Data

Performance

RXRX Performance
Metric	Value	Date
Price, 1Y	-23.04%	Nov 11, 26
Price, 3Y	-33.61%	Nov 11, 26
	-2.45%	Nov 11, 26
	+91.99%	Nov 11, 26
	+26.92%	Dec 31, 25
	+87.44%	Dec 31, 25
	+14.78%	Dec 31, 25
	-5.63%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

RXRX Technical Indicators
Metric	Value	Date
Current Price	$3.63	Nov 11, 26
	$3.49	Nov 10, 26
	$3.78	Nov 10, 26
	$3.78	Nov 10, 26
	$3.75	Nov 10, 26
	-$0.05	Nov 10, 26
	2.80	Nov 10, 26
	$0.36	Nov 10, 26
	45.27	Nov 10, 26
	98.86%	Nov 10, 26

Dividends

RXRX Dividends
Metric	Value	Date
	-	N/A
Upcoming	N/A	N/A
	-	Nov 11, 26
	-	Dec 31, 25
	$0.00	Dec 31, 25
	0.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

RXRX Income & Profitability
Metric	Value	Date
	$74.68M	Dec 31, 25
	-$1.44	Dec 31, 25
	$0.00	Dec 31, 25
	-61.96%	Dec 31, 25
	-$648.13M	Dec 31, 25
	-867.87%	Dec 31, 25
	-$644.76M	Dec 31, 25
	-863.35%	Dec 31, 25
	-$564.43M	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

RXRX Financial Health
Metric	Value	Date
	0.07	Dec 31, 25
	5.50	Dec 31, 25
	5.50	Dec 31, 25
	-	Dec 31, 25
	5	Sep 30, 26
	0.68	Nov 11, 26

Valuations

RXRX Valuations
Metric	Value	Date
	-	Nov 11, 26
	33.12	Nov 11, 26
	2.49	Nov 11, 26
	-4.22	Nov 11, 26
	-	N/A

Balance Sheet

RXRX Balance Sheet
Metric	Value	Date
	$1.13B	Dec 31, 25
	$747.89M	Dec 31, 25
	$1.53B	Dec 31, 25
	$812.85M	Dec 31, 25
	$397.49M	Dec 31, 25
	$147.71M	Dec 31, 25
	$77.97M	Dec 31, 25
	$21.75M	Dec 31, 25
	$18.12M	Dec 31, 25

Expenses

RXRX Expenses
Metric	Value	Date
	$719.44M	Dec 31, 25
	$601.86M	Dec 31, 25
	$120.95M	Dec 31, 25
	$0.00	Dec 31, 25
	$83.70M	Dec 31, 25
	$0.00	Dec 31, 25
	-$136.00K	Dec 31, 25

Cash Flow

RXRX Cash Flow
Metric	Value	Date
	-$371.81M	Dec 31, 25
	-$16.87M	Dec 31, 25
	$521.53M	Dec 31, 25
	$8.63M	Dec 31, 25
	-$380.44M	Dec 31, 25

Recent analyst updates

RXRX Recent analyst updates
Metric	Value	Date
Needham	→	Oct 19, 26
Morgan Stanley	→	May 14, 26
Needham	→	May 7, 26
JP Morgan	→	Apr 30, 26
Needham	→	Feb 26, 26
B of A Securities	→	Feb 26, 26
JP Morgan	→	Dec 17, 25
Needham	→	Sep 11, 25
Needham	→	Jul 8, 25
Morgan Stanley	→	Jun 16, 25

Analyst sentiment

Institutional ownership

Screeners with RXRX

FAQ

What is the ticker symbol for Recursion Pharmaceuticals, Inc.?: The ticker symbol for Recursion Pharmaceuticals, Inc. is NASDAQ:RXRX
Does Recursion Pharmaceuticals, Inc. pay dividends?: No, Recursion Pharmaceuticals, Inc. does not pay dividends
What sector is Recursion Pharmaceuticals, Inc. in?: Recursion Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Recursion Pharmaceuticals, Inc. in?: Recursion Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Recursion Pharmaceuticals, Inc. based in?: Recursion Pharmaceuticals, Inc. is headquartered in United States
When did Recursion Pharmaceuticals, Inc. go public?: Recursion Pharmaceuticals, Inc. initial public offering (IPO) was on April 16, 2021
Is Recursion Pharmaceuticals, Inc. in the S&P 500?: No, Recursion Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Recursion Pharmaceuticals, Inc. in the NASDAQ 100?: No, Recursion Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Recursion Pharmaceuticals, Inc. in the Dow Jones?: No, Recursion Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Recursion Pharmaceuticals, Inc. last earnings report?: Recursion Pharmaceuticals, Inc.'s most recent earnings report was on November 2, 2026
When does Recursion Pharmaceuticals, Inc. report earnings?: The next expected earnings date for Recursion Pharmaceuticals, Inc. is February 24, 2027

Data Sources & References

RXRX Official Website www.recursion.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1601830/000160183026000039/0001601830-26-000039-index.htm
RXRX Profile on Yahoo Finance finance.yahoo.com/quote/RXRX
RXRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rxrx